←AZN · $39.35

AstraZeneca xStock

AZN · Market closed

$39.35

0.00% today·exchange n/a

Jun 17$39.35 – $3,256.84Sep 22

1D 1W 1M 1Y

News · AstraZeneca xStock

Ionis Delivers Positive Late-Stage Results for Two Partnered Drugs
Zacks · 17h ago
AstraZeneca's Trixeo Secures Approval for Asthma in the EU
Zacks · 18h ago
European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance
Clinical Trials Arena · 18h ago
European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance
Pharmaceutical Technology · 18h ago
Novo Nordisk Stock Slides After Unveiling Long Term Pipeline Growth Targets
TIKR · 20h ago
Biotech is one area where the US can afford to let China flourish
Financial Times · 23h ago

Headlines from Yahoo Finance. Not investment advice.

About

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Industry: —
CEO: Pascal Claude Roland Soriot